Immunome Inc.
Develops targeted oncology therapies, like ADCs, for cancers with high unmet needs.
IMNM | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45257U1088
- LEI:
- Country:
- United States of America
- Address:
- 18702 N. CREEK PARKWAY, 98011 BOTHELL
- Website:
- https://immunome.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Immunome Inc. is a clinical-stage oncology company focused on developing first-in-class and best-in-class targeted therapies to improve outcomes for cancer patients. The company specializes in the discovery and development of differentiated treatments, particularly antibody-drug conjugates (ADCs), for cancers with high unmet needs. Its scientific approach involves a systematic, data-driven process to holistically optimize each therapeutic component—antibody, linker, and payload—for enhanced efficacy and tolerability. Immunome's pipeline features multiple candidates, including varegacestat, a gamma secretase inhibitor in a Phase 3 trial for desmoid tumors, alongside several ADCs and a radioligand therapy in clinical and preclinical stages for various solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Immunome Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Immunome Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Immunome Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
